Gastrointestinal Neoplasm Clinical Trial
Official title:
Kinase Genotyping of Gastrointestinal Stromal Tumors (GIST) From Patients Enrolled in the A6181112 Phase IIIb Trial at Participating U.S. and Ex-U.S. Medical Centers
The purpose of this study is to determine the genetic makeup of gastro intestinal stomach tumors (GISTs) from patients enrolled in the A6181112 phase IIIb trial. Tumor samples will be screened for mutations and this information will be used to determine whether the progression-free survival of patients being treated with the cancer medication sunitinib is related to the underlying genotype of their GIST.
In this companion study, we will analyze the genomic DNA from the GIST tumor specimens of patients enrolled in the in the A6181112 phase IIIb trial at participating U.S. and ex-U.S. medical centers. Specifically, GIST samples will be screened for mutations in KIT gene exons 9, 11, 13 and 17, and PDGFRA gene exons 12, 14 and 18, to determine the primary kinase genotype. Subset analyses will be performed and compared with the overall PFS rates observed in patients with primary and secondary imatinib resistance. Based on data from a previous phase I/II trial, our hypothesis is that patients with either primary or secondary imatinib resistance having a KIT exon 9-mutant or WT GIST will have a longer PFS when treated with sunitinib than patients with exon 11-mutant GIST. We further hypothesize that this difference will be observed among patients treated with high-dose imatinib. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Approved for marketing |
NCT00094029 -
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
|
N/A | |
| Not yet recruiting |
NCT06134687 -
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
|
N/A | |
| Completed |
NCT01621295 -
Assessing the Patient Experience in Cancer Care
|
N/A | |
| Withdrawn |
NCT03538613 -
Study of People With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System
|
Phase 1/Phase 2 | |
| Completed |
NCT02785783 -
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
|
N/A | |
| Completed |
NCT05172635 -
Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer
|
||
| Completed |
NCT01129310 -
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
|
Phase 2 | |
| Completed |
NCT03411915 -
A Study of XmAb®18087 in Subjects With NET and GIST
|
Phase 1 | |
| Completed |
NCT00052962 -
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
|
Phase 3 | |
| Recruiting |
NCT06159634 -
Traction vs. No Traction in Colonic ESD
|
N/A | |
| Completed |
NCT05320029 -
Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis
|
N/A | |
| Completed |
NCT00465725 -
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
|
Phase 1 |